This inventor holds 7 USPTO granted patents and 9 published patent applications and 7 EPO patents. Top assignee: Sygnis Bioscience Gmbh & Co Kg. Active years: 2008-2011.
Company Filing History:
Years Active: 2008-2011
Title: Armin Schneider: Innovator in Neurological Treatments
Introduction
Armin Schneider is a prominent inventor based in Heidelberg, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of neurological conditions. With a total of 7 patents to his name, Schneider's work has the potential to impact many lives.
Latest Patents
One of Schneider's latest patents focuses on methods of treating neurological conditions with hematopoietic growth factors. This invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor. His innovative approach aims to provide new therapeutic options for patients suffering from various neurological disorders.
Career Highlights
Throughout his career, Armin Schneider has worked with notable companies in the biotechnology sector. He has been associated with Sygnis Bioscience GmbH & Co. KG and Biogen Idec, Inc. These experiences have allowed him to develop and refine his inventions in a collaborative environment.
Collaborations
Schneider has collaborated with esteemed colleagues in his field, including Martin Maurer and Wolf-Ruediger Schaebitz. Their combined expertise has contributed to the advancement of research and development in neurological treatments.
Conclusion
Armin Schneider's innovative work in the treatment of neurological conditions showcases his dedication to improving patient outcomes. His patents and collaborations reflect a commitment to advancing medical science and providing hope for those affected by neurological disorders.